Table 2.
Author/Trial (Date) | Treatment | Base | HR | HRLCI | HRUCI | ||
---|---|---|---|---|---|---|---|
Burge/ISOLDE (2000) [15] | Fluticasone | Placebo | 0.76 | 0.51 | 1.13 | -0.276 | 0.203 |
Calverly/TORCH (2007) [16] | SFC | Placebo | 0.811 | 0.670 | 0.982 | -0.209 | 0.098 |
Salmeterol | Placebo | 0.857 | 0.710 | 1.035 | -0.154 | 0.096 | |
Fluticasone | Placebo | 1.056 | 0.883 | 1.264 | 0.055 | 0.092 | |
SFC | Salmeterol | 0.946 | 0.777 | 1.151 | -0.056 | 0.100 | |
SFC | Fluticasone | 0.768 | 0.636 | 0.927 | -0.264 | 0.096 |